Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHerlev and Gentofte Hospital
About this trial
No validated biomarkers exist that can identify patients with biliary tract cancer at an early stage or predict treatment outcomes. The objective of the present study is to find diagnostic, prognostic and predictive biomarkers.
Eligibility criteria
Qualifiers
Histological or cytological diagnosis of BTC
Patients referred for treatment of BTC
Signed informed consent
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov